Physiologically based pharmacokinetic modeling of POPs in Greenlanders

被引:14
|
作者
Sonne, Christian [1 ]
Gustayson, Kim [1 ]
Riget, Frank F. [1 ]
Dietz, Rune [1 ]
Kruger, Tanja [2 ]
Bonefeld-Jorgensen, Eva C. [2 ]
机构
[1] Aarhus Univ, Arctic Res Ctr, Dept Biosci, DK-4000 Roskilde, Denmark
[2] Aarhus Univ, Ctr Arctic Hlth, Dept Publ Hlth, DK-4000 Roskilde, Denmark
关键词
DDE; Greenland; HCB; Humans; Oxychlordane; PBPK modeling; PLASMA FATTY-ACIDS; DIETARY-COMPOSITION; EAST GREENLAND; CONTAMINANTS; EXPOSURE;
D O I
10.1016/j.envint.2013.12.006
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Human exposure to persistent organic pollutants (POPs) and the potential health impact in the Arctic far from the emission sources have been highlighted in numerous studies. As a supplement to human POP biomonitoring studies, a physiologically based pharmacokinetic (PBPK) model was set up to estimate the fate of POPs in Greenlandic Inuit's liver, blood, muscle and adipose tissue following long-term exposure to traditional Greenlandic diet. The PBPK model described metabolism, excretion and POP accumulation on the basis of their physicochemical properties and metabolic rates in the organisms. Basic correlations between chemically analyzed blood POP concentrations and calculated daily POP intake from food questionnaire of 118 middle age (18-35 years) Greenlandic Inuits from four cities in West Greenland (Qaanaaq: n = 40; Qeqertarsuaq: n = 36; Nuuk: n = 20; Narsaq: n = 22) taken during 2003 to 2006 were analyzed. The dietary items included were polar bear, caribou, musk oxen, several marine species such as whales, seals, bird and fish as well as imported food. The contaminant concentrations of the dietary items as well as their chemical properties, uptake, biotransformation and excretion allowed us to estimate the POP concentration in liver, blood, muscle and adipose tissue following long-term exposure to the traditional Greenlandic diet using the PBPK model. Significant correlations were found between chemically analyzed POP blood concentrations and calculated daily intake of POPs for Qeqertarsuaq, Nuuk and Narsaq Inuit but not for the northernmost settlement Qaanaaq, probably because the highest blood POP level was found in this district which might mask the interview-based POP calculations. Despite the large variation in circulating blood POP concentrations, the PBPK model predicted blood concentrations of a factor 2-3 within the actual measured values. Moreover, the PBPK model showed that estimated blood POP concentration increased significantly after consumption of meals. For individuals who had a high internal burden of POPs accumulated over years, the estimated blood levels were less influenced by recent meal intake. The model results also indicated that of the POPs accumulated in the body the concentrations were highest for CB-153 (oxychlordane: 0.6%; DDE and CB-99: 2.9%; HCB: 4.4%; CB-153: 34.5%). Furthermore, the model also estimated a significant internal body POP burden even several years after the mentioned dietetic shift and that contaminant accumulation was 2-6 folds faster than the decay after a shift to a diet low in contaminants. Using the PBPK model approach, we seek to improve the knowledge on contaminant body burden in humans of the Arctic. However, it should be noted that calculations of daily POP intake may be subject to considerable uncertainty due to imprecise information from the dietary interview. Based on these results we suggest that PBPK modeling is implemented as a tool in future human health exposure and effect assessments in Greenland. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [41] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF CHEMICAL DISPOSITION IN SKIN
    PECK, C
    CONNER, D
    SCHEUPLEIN, R
    DEDRICK, R
    MCDOUGAL, J
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (02) : 152 - 152
  • [42] Prediction of Fluoxetine and Norfluoxetine Pharmacokinetic Profiles Using Physiologically Based Pharmacokinetic Modeling
    Jeong, Hyeon-Cheol
    Chae, Yoon-Jee
    Lee, Sooyeun
    Kang, Wonku
    Yun, Hwi-yeol
    Shin, Kwang-Hee
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (11): : 1505 - 1513
  • [43] Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview
    Jia, Qiuyu
    He, Qingfeng
    Yao, Li
    Li, Min
    Lin, Jiaying
    Tang, Zhijia
    Zhu, Xiao
    Xiang, Xiaoqiang
    MOLECULES, 2022, 27 (24):
  • [44] Adult and infant pharmacokinetic profiling of dihydrocodeine using physiologically based pharmacokinetic modeling
    Ota, Miki
    Shimizu, Makiko
    Kamiya, Yusuke
    Emoto, Chie
    Fukuda, Tsuyoshi
    Yamazaki, Hiroshi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2019, 40 (09) : 350 - 357
  • [45] Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles
    Deng, Linjing
    Liu, Hui
    Ma, Yongsheng
    Miao, Yufeng
    Fu, Xiaoli
    Deng, Qihong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 384
  • [46] The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement
    Poggesi, Italo
    Snoeys, Jan
    Van Peer, Achiel
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 631 - 635
  • [47] Physiologically Based Pharmacokinetic and Absorption Modeling for Osmotic Pump Products
    Ni, Zhanglin
    Talattof, Arjang
    Fan, Jianghong
    Tsakalozou, Eleftheria
    Sharan, Satish
    Sun, Dajun
    Wen, Hong
    Zhao, Liang
    Zhang, Xinyuan
    AAPS JOURNAL, 2017, 19 (04): : 1045 - 1053
  • [48] Physiologically-Based Pharmacokinetic Modeling: Parameter Estimation for Cyclosporin A
    Lueshen, Eric
    Hall, Cierra
    Mosat, Andrej
    Linninger, Andreas
    21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 1543 - 1547
  • [49] Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
    Maharaj, A. R.
    Edginton, A. N.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (11):
  • [50] Biological monitoring: The role of toxicokinetics and physiologically based pharmacokinetic modeling
    Mason, H
    Wilson, K
    AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1999, 60 (02): : 237 - 242